ReviewCureus2026

Modern Obesity Treatment: Efficacy, Safety, and Future Directions of GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) Receptor Agonists.

Dorota Bartkowiak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.